Skip to main content
ConductScienceScienceDex

Dori A Thomas-Karyat

From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.

FY2025 NIH rank #10,933
Unclaimed recordClaim profile
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 14659602Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2025

Linked Award Amount
$1.4M
Full award amounts, FY2025
Award Records
1
Records listing this PI
Award-Linked Rank
#10,933
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Dori A Thomas-Karyat. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Dori A Thomas-Karyat as a PI. Multi-PI records show the full award amount for context.

  • 5R44CA291368-02R44Contact PI
    In vivo efficacy, safety and PK/PD analysis of SYN101, a first in class, immune cell targeted TGFb therapy for cancer patients
    Synthis Therapeutics, Inc.
    $1.4M
    award amount

Award organization

Organizations that administered FY2025 awards listing Dori A Thomas-Karyat as a PI.

FY2025 award administered by Synthis Therapeutics, Inc. (NY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Synthis Therapeutics, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding

Explore further

Find collaborators for Dori A Thomas-Karyat

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →